The Buffalo News : Opinion

Saturday, November 7, 2009

Web Search powered by YAHOO! SEARCH
subscribe now

Genetic test can reveal a painful truth

McCLATCHY NEWSPAPERS

Story tools:

More Photos

<i></i><br /> CONFRONTING CANCER Inset photo by Getty Images; photo by Business Wire<i>Getty Images</i><br /> Christina Applegate, who carries the BRCA1 gene mutation, decided to have a double mastectomy after being diagnosed with breast cancer in July.

SOUTHLAKE, Texas — Wanda Stutsman was 32 years old and seven months pregnant when she began her first round of chemotherapy. Two months later — exhausted and bald from the chemo — she delivered a healthy son with a full head of hair. But there was little time to dote on him; Stutsman had to move quickly to the next phase of her breast cancer treatment: six weeks of radiation therapy.

Although the radiation zapped her energy and the baby kept her up all night, Stutsman managed to get through her final treatment.

She went on with her life, getting annual mammograms to make sure the cancer had not returned. After a decade without a reoccurrence, she managed to push cancer to the back of her mind.

That is, until her cousin was diagnosed with ovarian cancer three years ago. Stutsman decided it was time to be tested for BRCA1 and BRCA2, mutated genes that are linked to breast and ovarian cancer. “I found out I have BRCA1,” she said. “I went 10 years as a survivor without ever knowing I was in this small group of women who have a high risk for breast cancer.”

Only 5 percent to 10 percent of breast cancers are caused by these genetic changes. But those who have the mutation face a 36 percent to 85 percent chance of being diagnosed with breast cancer at some point, according to the National Cancer Institute.

Had it come when she had cancer, the discovery might have caused Stutsman to opt for more than a lumpectomy, chemotherapy and radiation.

But 10 years had passed, and she wasn’t all that worried for herself. A new fear did keep her awake at night, however: Had she passed the mutation on to her two children?

It’s an issue more women are wrestling with as the demand for genetic testing grows. Last year, about 100,000 tests for the breast cancer genes were performed in the United States, double the number from 2005, the Associated Press reported.

In the past, the cost of testing and a fear that insurance companies would discriminate against someone with the gene mutation kept many women from pursuing it, said Dr. Prasanthi Ganesa, an oncologist at the Center for Cancer and Blood Disorders in Fort Worth.

Then insurance companies started covering the test, which

costs about $3,000. In 1996, the federal Health Insurance Portability and Accountability Act prohibited group insurance plans from using genetic information as a basis for denying coverage. In 2000, federal regulations were expanded to protect the privacy of medical records.

These changes, combined with dramatic improvements in reconstructive surgery and a heightened awareness of the breast cancer genes, have contributed to the increase in testing.

This year, actress Christina Applegate made headlines when she had a double mastectomy a few months after being diagnosed with breast cancer and learning she carried the BRCA1 gene mutation.

Stutsman said she might have undergone a double mastectomy had she known she was BRCA1-positive at the time of her cancer diagnosis.

After the positive test, she had to rethink her strategy. She decided against surgery to remove her healthy breasts, but this summer she had her ovaries removed.

In addition to having an increased risk of breast cancer, women with the BRCA1 mutation also have a 20 percent to 40 percent chance of getting ovarian cancer, Ganesa said. BRCA2 carries an even higher risk of ovarian cancer.

But the risks don’t stop there. Men who carry a BRCA mutation have a greater risk of pancreatic, colon and prostate cancer.

At the time of her diagnosis, Stutsman had no reason to suspect that breast cancer ran in her family.

Then her cousin found out she had ovarian cancer, and her sister was diagnosed with breast cancer. That brought the tally to three.

There was no cancer on her mother’s side, but when she traced her father’s roots, Stutsman found that an aunt and a great-aunt had the disease.

If either parent carries the gene mutation, children have a 50-50 chance of inheriting it. They could then pass it on to the next generation. It’s a risk that weighs on parents, who must decide when to tell their children.

“I will have my daughter tested when she is 18,” Stutsman said. “I see no reason to test her prior to that.”

The Susan G. Komen Foundation recommends that breast self-exams begin by age 20. It is extremely rare for girls younger than 18 to get the disease. The risk by age 20 is 1 in 1,985, according to the American Cancer Society.

Knowing that their mothers have tested positive, some girls want to know their risk immediately. But young girls are often ill-prepared to deal with the results, and the American Society of Clinical Oncology advises against testing children who are too young to be candidates for surgeries to prevent breast or ovarian cancer.

Physicians discourage the removal of the breasts or ovaries in healthy women who are 25 or younger.

Whether to have a mastectomy depends on the woman’s personality, her family’s influence and her anxiety level.

“Some women just say, ‘Take the breasts off,’ ” Ganesa said.

Knowing that good reconstructive surgery is available helps with the decision.

“Cosmeticly, you can’t tell that a woman had a mastectomy,” she said.

After their childbearing years, most women with the gene mutation want their ovaries removed, largely because ovarian cancer is hard to detect and is so deadly, Ganesa said.

Although only a small percentage of breast cancers are hereditary, Stutsman said she would urge any young woman with breast cancer to undergo genetic testing.

In her case, knowing her family history has meant worrying more about what her daughter might go through if she has the gene. But she copes by raising money and volunteering with Komen for the Cure in Tarrant County.

“It is a scary thing,” Stutsman said. “I know in my heart she probably does.”


Reader comments

There on this article.
Rate This Article
Comments are moderated by users and Buffalo News staff.
Learn more about our moderation system.

Log into MyBuffalo to post a comment





What is MyBuffalo?
MyBuffalo is the new social network from Buffalo.com. Your MyBuffalo account lets you comment on and rate stories at buffalonews.com. You can also head over to mybuffalo.com to share your blog posts, stories, photos, and videos with the community. Join now or learn more.
sort comments:

Buffalo News Video


Breaking News Video

Breaking 24 Hour News

more >>

More Opinion Stories

Most Viewed Stories, Last 24 Hours